2024³â Á¦75Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷) : 2024-04-18
±³À°ÀÏÀÚ : 2024-04-18
±³À°Àå¼Ò : ·Ôµ¥È£ÅÚ ºÎ»ê
±³À°ÁÖÁ¦ : 2024³â Á¦75Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
´ã´çÀÚ : ´ëÇÑÇǺΰúÇÐȸ
¿¬¶ôó : 02-3473-0284
À̸ÞÀÏ : kda@derma.or.kr
±³À°Á¾·ù : ÇǺΰú
Âü¼®¿¹»óÀÎ : 800¸í
Èñ¸ÁÆòÁ¡ : 6Á¡ (ÀÏ¹Ý 4Á¡ / Çʼö 2Á¡)
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 26 ½Ã°£ 35ºÐ
¼¼ºÎ¼ö°·á : 500,000¿ø
ºñ°í Á¤È¸¿ø 80,000 / ÁØȸ¿ø 40,000 / ºñȸ¿ø 500,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 12:30~12:35 Introduction Chair(-)
±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 12:35~13:20 Skin disease treatment targeting itch Takeshi Nakahara(Kyushu University Fukuoka Japan)
Åä·Ð 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 13:20~13:30 Q&A -(-)
±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 15:00~15:25 ÃÊ·Ï Epigenetics in skin inflammation ±è¶ô±Õ(¿¬¼¼´ë ÀÇ»ý¸í°úÇкÎ)
±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 15:25~15:40 ÃÊ·Ï Alcohol and smoking in skin disorders À̼־Ï(¿¬¼¼¿øÁÖÀÇ´ë)
±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 15:40~15:55 ÃÊ·Ï Exercise in skin health Á¤ÁعÎ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 15:55~16:10 ÃÊ·Ï Systemic photoprotection and skin cancer prevention ±èÁ¤Àº(ÇѾçÀÇ´ë)
Åä·Ð 04¿ù 18ÀÏ »çÆÄÀ̾î 16:10~16:20 Panel discussion ±èÁ¤Àº ±è¶ô±Õ ÀÌ¼Ö¾Ï Á¤ÁعÎ(-)
±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 16:20~16:24 ÃÊ·Ï Raise an issue with representative cases ÀÌÁß¼±(À»ÁöÀÇ´ë)
±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 16:24~16:37 ÃÊ·Ï Oral and topical medication for a red face: My pearls ±èÇý¼º(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 16:37~16:50 ÃÊ·Ï When and how to apply EBD on a red face Á¤º¸¿µ(ÇѸ²ÀÇ´ë)
Åä·Ð 04¿ù 18ÀÏ »çÆÄÀ̾î 16:50~17:00 Panel discussion ÀÌÁß¼± ±èÇý¼º Á¤º¸¿µ(-)
±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 13:30~13:45 ÃÊ·Ï Systematic approach and work-up of cutaneous vasculitis ÀÌ»óÀº(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 13:45~14:00 ÃÊ·Ï Management of refractory cutaneous vasculopathy Á¶¼Ò¿¬(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 14:00~14:20 ÃÊ·Ï Laser pearl of common but troublesome vascular lesions ¿Àâ±Ù(¿ÀÁîÇǺΰú)
Åä·Ð 04¿ù 18ÀÏ »çÆÄÀ̾î 14:20~14:30 Q&A -(-)
±³À°½Ã°£ 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 15:00~15:30 ÃÊ·Ï Practical applications of ultrasound in dermatology, Video training ±è¿µÈ£(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 15:30~15:50 ÃÊ·Ï Imaging work-up in skin cancer patients ³ë¹Ì·É(¿¬¼¼ÀÇ´ë)
Åä·Ð 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 15:50~16:00 Q&A -(-)
±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 16:00~16:30 ÃÊ·Ï Next generation sequencing for diagnosing neurofibromatosis and cafe-au-lait macule ½ÅÇöÅÂ(ÀÎÇÏÀÇ´ë)
±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 16:30~17:00 ÃÊ·Ï Gene therapy as a paradigm change in medicine ±è¿¬¼ö(Ãæ³²´ë ½Å¾àÀü¹®´ëÇпø)
±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 12:30~12:43 ÃÊ·Ï Types and mechanisms of zoster and other vaccines Á¤ÀÇÇö(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 12:43~13:02 ÃÊ·Ï Con ½Å±âÇõ(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 13:02~13:21 ÃÊ·Ï Pro ÃÖÁ¾¿ø(¼¿ïÀÇ´ë)
Åä·Ð 04¿ù 18ÀÏ »çÆÄÀ̾î 13:21~13:30 Debates Q&A -(-)
±³À°½Ã°£ 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 16:00~16:18 ÃÊ·Ï Alopecia, skin cancer ¿øÁ¾Çö(¿ï»êÀÇ´ë)
±³À°½Ã°£ 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 16:18~16:36 ÃÊ·Ï Psoriasis, dermatitis ¹ÚÁؼö(´ë±¸°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 16:36~16:54 ÃÊ·Ï Acne, rosacea, hidradenitis suppurativa, and etc. ±èÁ¤Àº(¼øõÇâÀÇ´ë)
Åä·Ð 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 16:54~17:00 Q&A -(-)
±âŸ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 10:00~10:05 Overview Chair(-)
±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 10:05~10:20 ÃÊ·Ï Cutaneous adverse effects of chemotherapeutic drugs ¹Ú»óÇö(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 10:20~10:35 ÃÊ·Ï Cutaneous adverse effects of targeted therapies Á¶¼ºÁø(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 10:35~10:50 ÃÊ·Ï Cutaneous adverse effects of immune checkpoint inhibitors º¯Áö¿ø(ÀÎÇÏÀÇ´ë)
Åä·Ð 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 10:50~11:00 Q&A -(-)
±âŸ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 12:30~12:35 Overview Chair(-)
±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 12:35~12:50 ÃÊ·Ï Biomarkers in psoriasis and psoriatic arthritis ±èÀ±¼·(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 12:50~13:05 ÃÊ·Ï Multi-morbidity of psoriasis: What dermatologists should know Á¤ÇýÁ¤(±¹¸³Áß¾ÓÀÇ·á¿ø)
±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 13:05~13:20 ÃÊ·Ï Educating and engaging patients in treatment Á¤°æÀº(Ãæ³²ÀÇ´ë)
Åä·Ð 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 13:20~13:30 Q&A -(-)
±âŸ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 13:30~13:35 Overview Chair(-)
±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 13:35~13:50 ÃÊ·Ï The concept of disease modification in atopic dermatitis ³ªÂùÈ£(Á¶¼±ÀÇ´ë)
±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 13:50~14:05 ÃÊ·Ï The identification biomarkers and prediction of treatment response in AD Àå¿ëÇö(°æºÏÀÇ´ë)
±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 14:05~14:20 ÃÊ·Ï Update on the novel treatment of atopic dermatitis ÀÌ»óÀº(¿¬¼¼ÀÇ´ë)
Åä·Ð 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 14:20~14:30 Q&A -(-)
±âŸ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 16:00~16:05 Overview Chair(-)
±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 16:05~16:20 ÃÊ·Ï Practical tips for effective phototherapy in dermatology ¿À»óÈ£(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 16:20~16:35 ÃÊ·Ï Ensuring safety in phototherapy through understanding photosensitive conditions ¹æöȯ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 16:35~16:50 ÃÊ·Ï Application of home-based phototherapy for skin disorders based on the effects and side effects Á¤±âÇå(°æÈñÀÇ´ë)
Åä·Ð 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 16:50~17:00 Q&A -(-)
±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 09:00~09:10 ÃÊ·Ï Surgical anatomy of head and neck ¿Àº´È£(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 09:10~09:20 ÃÊ·Ï Local and regional anesthesia ÃÖ¿µÁØ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 09:20~09:30 ÃÊ·Ï Various biopsy methods and suture technique º¯Áö¿ø(ÀÎÇÏÀÇ´ë)
±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 09:30~09:40 ÃÊ·Ï How to design and perform basic two layer wound closure ±èÈƼö(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 09:40~11:00 ÃÊ·Ï Let¡¯s master conventional two layer wound closure! ³ë¹Ì·É(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 13:30~14:20 ÃÊ·Ï How to improve the journals published by the Korean Dermatological Association ÀÌÀº¼Ò(¾ÆÁÖÀÇ´ë)
Åä·Ð 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 14:20~14:30 Q&A -(-)
±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 15:00~15:50 ÃÊ·Ï Grateful journey as a dermatologic surgeon in Korea Á¤±â¾ç(¿¬¼¼ÀÇ´ë)
Åä·Ð 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 15:50~16:00 Q&A -(-)
±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 09:00~10:00 Managements of STD and changes of surveillance system for syphilis À̼öÁø(ºÎ»êÀÇ´ë °¨¿°³»°ú) Çʼö
±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 15:00~16:00 Medical disputes: What dermatologists need to know À¯ÈÁø(À¯ÈÁøº¯È£»ç »ç¹«½Ç) Çʼö
±âŸ 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 08:00~08:10 Àλ縻 °ÈÆ(ȸÀå)
±âŸ 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 08:10~08:40 ´ëÇÑÇǺΰúÇÐȸ ¼Ò°³ À±»ó¿õ(Ãѹ«ÀÌ»ç)
±³À°½Ã°£ 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 08:40~09:20 ÇǺΰú Àü°øÀÇ ¿¬Â÷º° ¼ö·Ã ¸ñÇ¥ ¹× ³»¿ë ¾ÈÈ¿Çö(±³À°ÀÌ»ç)
±³À°½Ã°£ 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 09:20~10:00 ÇǺΰú Àü°øÀÇ ¼ö·Ã °úÁ¤ÀÇ Æò°¡ ¾ÈÈ¿Çö(±³À°ÀÌ»ç)
±³À°½Ã°£ 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 10:00~10:40 ÇǺΰú Àü¹®ÀÇ ÀڰݽÃÇè (2025) °³¿ä ¿À»óÈ£(°í½ÃÀÌ»ç)
±³À°½Ã°£ 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 10:40~11:20 Àü¹®ÀÇ ÀڰݽÃÇè ¹Ù¸£°Ô ÃâÁ¦Çϱâ!! ¹Ú¿µ¹Î(°í½ÃÀ§¿øÀå)
±³À°½Ã°£ 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 11:20~12:00 ³í¹®ÀÛ¼º¹ý ÀÌ°æÈ£(°£ÇàÀÌ»ç)
Åä·Ð 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 12:00~12:10 Q&A -(-)
±âŸ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 11:10~11:15 Introduction Chair(-)
±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 11:15~11:55 ÃÊ·Ï First-in-class and only selective allosteric TYK2 inhibitor Akimichi Morita(Nagoya City University Graduate School of Medical Sciences)
Åä·Ð 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 11:55~12:10 Q&A -(-)
±âŸ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 11:10~11:15 Introduction Chair(-)
±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 11:15~11:50 ÃÊ·Ï Unleashing the power of dual inhibition and IL-4 blockade by dupilumab in AD and PN °íÇöâ(ºÎ»êÀÇ´ë)
Åä·Ð 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 11:50~12:00 Q&A -(-)
±âŸ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 08:00~08:05 Introduction -(-)
±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 08:05~08:25 ÃÊ·Ï Reality Check - Achieving complete clear skin in psoriasis with biologics in real-life setting ¹ÚÁؼö(´ë±¸°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 08:25~08:45 ÃÊ·Ï Spotlighting itch - Considering persistent itch when making treatment decisions for your AD patients À̵¿ÈÆ(¼¿ïÀÇ´ë)
Åä·Ð 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 08:45~09:00 Q&A -(-)
±âŸ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 08:00~08:05 Introduction -(-)
±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 08:05~08:25 ÃÊ·Ï A durable, safe and simple journey to completely clear skin with risankizumab Á¶¼ºÁø(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 08:25~08:45 ÃÊ·Ï An early, safe and lasting journey to minimal AD control with upadacitinib ¹Úâ¿í(¿¬¼¼ÀÇ´ë)
Åä·Ð 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 08:45~09:00 Q&A -(-)
±³À°½Ã°£ 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 12:30~13:10 ÃÊ·Ï Precise diagnosis of onychomycosis and latest treatment guideline update °ÇöÁö(Áß¾Óº¸Èƺ´¿ø)
Åä·Ð 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 13:10~13:30 Q&A -(-)
±³À°½Ã°£ 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 13:30~14:10 ÃÊ·Ï Considerations of DMF for psoriasis in real world experience Á¤±âÇå(°æÈñÀÇ´ë)
Åä·Ð 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 14:10~14:30 Q&A -(-)